2009
DOI: 10.2175/193864709793954880
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Active Pharmaceutical Ingredients at Publicly Owned Treatment Works

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Table 1 represents general characteristics of those five different TOrCs. Various techniques and processes have been employed for the removal of these TOrCs and other endocrine disrupting compounds (EDCs), ranging from the activated sludge process and biodegradation, advanced oxidation process, granulated activated carbon, membrane bioreactor (MBR) and other non-biological methods such as nano filtration, reverse osmosis and ultra-violet (UV) processes (Johnson & Sumpter 2001;Holbrook et al 2002;Urase & Kikuta 2005;Tischler et al 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Table 1 represents general characteristics of those five different TOrCs. Various techniques and processes have been employed for the removal of these TOrCs and other endocrine disrupting compounds (EDCs), ranging from the activated sludge process and biodegradation, advanced oxidation process, granulated activated carbon, membrane bioreactor (MBR) and other non-biological methods such as nano filtration, reverse osmosis and ultra-violet (UV) processes (Johnson & Sumpter 2001;Holbrook et al 2002;Urase & Kikuta 2005;Tischler et al 2009).…”
Section: Introductionmentioning
confidence: 99%